|
|
 Lunchtime
Activity |
| 12:30 PM-1:30 PM |
| Wednesday
| April 23, 2008 |
#1. Clinical Impact
of a Pro-Healing Stent
Coronary Arena, Level 1
Co-sponsored by Orbus Neich Medical Korea, Ltd |
| Moderator: Seung-Jung Park
|
| Panelists:
Robbert De Winter, Michael J.B. Kutryk, Harry Suryapranata |
| 12:30 PM |
Welcome Address |
Seung-Jung Park |
| 12:35 PM |
Endothelial
Progenitor Cell Capture Technology and Beyond  |
Michael J.B. Kutryk |
| 12:50 PM |
TRIAS
HR Pilot Study Long Term Follow-Up
|
Robbert De Winter |
| 1:05 PM |
Healing AMI |
Harry Suryapranata |
| 1:20 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#2. Antiplatelet Therapy
for Atherothrombotic Disease: The Evidence from Clinical Trials into
Real Practice
Endovascular Arena, Level 1
Sponsored by Bristol-Myers Squibb Korea |
| Moderator: Ron Waksman |
| 12:30 PM |
Welcome Address |
Ron Waksman |
| 12:35 PM |
Insights
into Antiplatelet Therapy: From CAPRIE to TRITON-TIMI 38 |
Cheol Whan Lee |
| 12:50 PM |
How
Long Patients Will Be on Dual Antiplatelet Therapy? |
Ron Waksman |
| 1:10 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#3. New Insight of
Management for High-Risk Group in DES Era
Room 2-1, Level 2
Sponsored by Korea Otsuka Pharmaceutical Co., Ltd. |
| Moderator: Young Jo Kim |
| 12:30 PM |
Welcome Address |
Young Jo Kim |
| 12:35 PM |
Is
Triple Anti-Platelet Therapy a Solution for Patients with Aspirin/Plavix
Resistance ? |
Jung Won Seo |
| 12:55 PM |
Triple
Antiplatelet Therapy After DES Implantation in Patients with High
Risk of Restenosis |
Seong-Wook Park |
| 1:15 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#4. Angiomyogenesis
Symposium
Room 2-2, Level 2
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderator: Hyo-Soo Kim |
| 12:30 PM |
Welcome Address |
Hyo-Soo Kim |
| 12:35 PM |
Progenitor Cell Transfer Strategies in Myocardial
Infarction: Insights from (pre)Clinical Studies |
Stefan Janssens |
| 1:00 PM |
Stem Cell Therapy in Myocardial Infarction:
Insight from MAGIC Cell Trials |
Hyun Jae Kang |
| 1:25 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#5. Moderated Oral
Abstract Presentation Competition
"Drug-Eluting Stent I"
Room 2-3, Level 2
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderators: Adnan Kastrati,
Seung-Jea Tahk |
| Panelists:
Young-Keun Ahn, Ted Feldman, Ashok Seth, Marco Valgimigli |
| 12:30 PM |
AS-19, Long-Term Predictors of Cardiac Death
After Unprotected Left Main Stenting: Insights From the French Left
Main Taxus Registry |
Beatriz Vaquerizo |
| 12:40 PM |
AS-20, Influence of Distal Bifurcation Involvement
on Long-Term Clinical Events In Patients Undergoing Revascularization
for Unprotected Left Main Disease |
Won-Jang Kim |
| 12:50 PM |
AS-21, Use of A Biodegradable Polymer Based
Biolimus A9-Eluting Stent In Real World Cases: One-year Follow-up
of a Single Center Experience |
Teguh Santoso |
| 1:00 PM |
AS-22, Late Restenosis After Stenting In
Chronic Total Occlusions: A Comparison Between Bare Metal Stent and
Sirolimus-Eluting Stent Implantation |
Hiroyuki Tanaka |
| 1:10 PM |
AS-23, Long-Term Outcomes of Intervention
for Unprotected Left Main Coronary Artery Stenosis: Coronary Stenting
vs. Coronary Artery Bypass Graft Surgery |
Cheng-I Cheng |
| 1:20 PM |
Best Abstract Selection & Announcement |
|
| |
|
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#6. Journey of Optimal
Hypertension Treatment Across the Continuum
Symposium Arena, Level 3
Sponsored by NOVARTIS Korea Ltd. |
| Moderators: Joo-Young Yang,
Junghan Yoon |
| 12:30 PM |
Welcome Address |
|
| 12:35 PM |
Improving
Outcomes in CV & Metabolic Disease, Landmark Trials Across the
Continuum |
Dong-Ju Choi |
| 12:50 PM |
Explore
the Rationale for the Dual Mechanism CCB/ARB Approaches in Hypertension
Management |
Jeong Bae Park |
| 1:10 PM |
ASPIRE
HIGHER: Are There Still Existing Unmet Needs? What We Expect from
New Anti-Hypertensive Treatment |
Sang-Hong Baek |
| 1:25 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#7. Beyond the Horizon
- Inspire Your Confidence
Room 4-1, Level 4
Sponsored by Boston Scientific Korea |
| Moderators: Yang-Soo Jang,
Matin B. Leon |
| 12:30 PM |
Welcome Address |
|
| 12:35 PM |
Diabetes & Cardiovascular Disease |
Moon-Kyu Lee |
| 12:50 PM |
TAXUS Stent Performance in Diabetes |
Matin B. Leon |
| 1:05 PM |
Boston Scientific DES Program: PROMUS &
Future Pipeline |
Keith D. Dawkins |
| 1:20 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
|
Evening Satellite Symposia |
| 6:00 PM-9:00 PM |
| Wednesday |
April 23, 2008 |
#1. Imaging Summit:
VH-IVUS and OCT
"Clinical Application, Experience, and Future Utility"
Coronary Arena, Level 1
Co-sponsored by Volcano Corporation & FOCUSMEDICAL CO.,LTD, GOODMAN
KOREA, LightLab Imaging, Inc. |
| Moderators: James R. Margolis,
Gary S. Mintz |
| Panelists:
Takashi Akasaka, Chong-Jin Kim, Kenya Nasu, Duk Woo Park |
| 6:20 PM |
Dinner Reception & Welcome Address |
Gary S. Mintz |
| 6:30 PM |
VH
Registry and Clinical Trial Data Review
|
James R. Margolis |
| 6:50 PM |
VH
AMC Clinical Experience |
Duk Woo Park |
| 7:10 PM |
VH and OCT Correlations |
Kenya Nasu |
| 7:30 PM |
Assessment
of Vulnerable Plaque by OCT: Comparison Among Intravascular Imaging
Modalities |
Takashi Akasaka |
| 7:50 PM |
VH
and OCT Clinical Experience and Future Perspective |
Gary S. Mintz |
| 8:10 PM |
Q&A |
|
| 8:30 PM |
Adjourn |
|
| |
|
|
#2. PCI Evolvement
Through Clinical Evidence in DES Era
Endovascular Arena, Level 1
Co-sponsored by Johnson & Johnson Medical Korea |
| Moderator: Seung-Jung Park
|
| Panelists:
Taehoon Ahn, Young-Keun Ahn, Dong Hoon Choi, Seung-Ho Hur, Ki-Bae
Seung |
| 6:40 PM |
Dinner Reception & Welcome Address |
Seung-Jung Park |
| 6:50 PM |
The Zig-Zag Path of Drug-Eluting Stents
- From Enthusiasm to Panic to Truth |
Adnan Kastrati |
| 7:20 PM |
Current and Future Perspectives on Drug-Eluting
Stents |
Bernhard Meier |
| 7:50 PM |
Real World Experience in J-Cypher Registry
|
Takeshi Kimura |
| 8:20 PM |
Adjourn |
|
| |
|
|
#3. Recent Advances
in Next Generation Drug Eluting Stents
Symposium Arena, Level 3
Co-sponsored by Abbott Vascular & CrossRoad Institute |
| Moderator: Seung Jea Tahk
|
| Panelists:
In-Ho Chae, Hyeon-Cheol Gwon, Do Sun Lim, Hun-Sik Park, Chris Kwok
Yiu Wong, Junghan Yoon |
| 6:00 PM |
Dinner Reception & Welcome Address |
|
| 6:30 PM |
Xience V: A True Next Generation DES |
Eulogio Garcia |
| 7:00 PM |
Pre-Clinical Assessment of Xience V |
Renu Virmani |
| 7:30 PM |
The Superior Clinical Outcomes of Xience
V |
Patrick W. Serruys |
| 8:00 PM |
Q&A |
|
| 8:30 PM |
Adjourn |
|
| |
|
|
#4. A New Era in PCI
: Endeavor & Endeavor Resolute Perspective
Room 4-1, Level 4
Co-sponsored by Medtronic, Inc. |
| Moderators: Yang-Soo Jang,
Seong-Wook Park |
| Panelists:
Rodney S. Badger, Myeong-Chan Cho, Kyoo-Rok Han, Myeong-Ki Hong, Myung-Ho
Jeong, Hyo-Soo Kim, Michael Kang-Yin Lee |
| 6:00 PM |
Dinner Reception & Welcome Address |
|
| 7:00 PM |
Safety Profile of Endeavor Stent Family:
PC & Biolinx |
Rodney S. Badger |
| 7:20 PM |
Safety of DES in Korea: Acute Myocardial
Infarction Registry |
Myung-Ho Jeong |
| 7:40 PM |
Endeavor Resolute: The Next Frontier |
Ian T. Meredith |
| 8:00 PM |
Endeavor Pooled Data |
Martin B. Leon |
| 8:20 PM |
Q&A |
|
| 8:30 PM |
Adjourn |
|
|
Lunchtime
Activity |
| 12:30 PM-1:30 PM |
| Thursday|
April 24, 2008 |
#1. NOBORI - Adding
Safety to Clinical Efficacy
Coronary Arena, Level 1
Co-sponsored by Terumo Korea Corporation |
| Moderator: Gian Battista Danzi
|
| Panelists:
Bernard Chevalier, Young-Hak Kim, Renu Virmani |
| 12:30 PM |
Welcome Address |
Gian Battista Danzi |
| 12:35 PM |
Role of Endothelial for Long-Term Safefy
|
Renu Virmani |
| 12:55 PM |
NOBORI 1 |
Bernard Chevalier |
| 1:15 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#2. How Statin Works
in Atherosclerosis
Endovascular Arena, Level 1
Sponsored by AstraZeneca Korea |
| Moderator: Seung-Jung Park |
| 12:30 PM |
Welcome Address |
Seung-Jung Park |
| 12:35 PM |
Relationship Between Atherosclerosis and
CV Outcomes |
James Kuang-Jan Liao |
| 1:00 PM |
Recent Update on Atherosclerosis Studies |
Myeong-Ki Hong |
| 1:20 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#3. New Insights into
Treatment of High Risk Patients
Room 2-1, Level 2
Sponsored by Pfizer Pharmaceutical Korea Ltd. |
| Moderator: Jeong Euy Park
|
| 12:30 PM |
Welcome Address |
Jeong Euy Park |
| 12:35 PM |
Current Opinion in Lipid Management: LDL
Hypothesis Under Attack |
In-Ho Chae |
| 12:55 PM |
Protective Effect of Atherosclerosis Using
CCBs and Statins |
Seung-Woo Park |
| 1:15 PM |
Q&A |
|
| 1:25 PM |
Closing Address |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#4. Moderated Oral
Abstract Presentation Competition
"Acute Coronary Syndrome"
Room 2-3, Level 2
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderators: David R. Holmes,
Mun Kyung Hong |
| Panelists:
Seung-Ho Hur, David E. Kandzari, Jong-Seon Park, Biao Xu |
| 12:30 PM |
AS-5, Enoxaparin vs. Unfractionated Heparin
as Adjunctive Anticoagulant Therapy in Patients Treated with Primary
Percutaneuous Coronary Intervention for ST-Elevation Myocardial Infarction |
Deuk-Young Nah |
| 12:40 PM |
AS-6, Impact of Coronary Microvascular Resistance
Index Immediately After Primary Percutaneous Coronary Intervention
on Myocardial Viability in Acute Myocardial Infarction |
Hironori Kitabata |
| 12:50 PM |
AS-7, Systematic Review of the Effect of
Intracoronary Autologous Bone Marrow Stem Cells Transfer on Left Ventricular
Function After Acute Myocardial Infarction |
Shu Ning Zhang |
| 1:00 PM |
AS-8, Myocardial Viability Assesed by FDG-PET
As a Predictor of Cardiac Events in Patients with Acute Myocardial
Infarction |
Masanori Tsurugida |
| 1:10 PM |
AS-9, Clinical Safety of Drug Eluting Stents
in Korea Acute Myocardial Infarction Registry |
Sang Rok Lee |
| 1:20 PM |
Best Abstract Selection & Announcement |
|
| |
|
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#5. Reducing Residual
CV Risk -The Need to Look Beyond LDL-C
Symposium Arena, Level 3
Sponsored by MSD Korea |
| Moderator: Ki Hoon Han |
| 12:30 PM |
Welcome Address |
Ki Hoon Han |
| 12:35 PM |
Looking Beyond LDL: Epidemiological Evidence
in Asia & Korea |
Sun Ha Ji |
| 12:55 PM |
Emerging Science of HDL and the Novel Targeted
Therapies |
Karam Maximilian Kostner |
| 1:25 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#6. Update on Management
of PAD
Room 4-1, Level 4
Sponsored by Johnson & Johnson Medical Korea |
| Moderator: Seong-Wook Park |
| 12:30 PM |
Welcome Address |
Seong-Wook Park |
| 12:35 PM |
Long-Term Efficacy of Endovascular Treatment
& PVD Treatment: Tips & Tricks |
Dierk Scheinert |
| 1:05 PM |
Case Presentation 1 - Cardiology's Perspective
on Angioplasty of PAD |
Weon Kim |
| 1:15 PM |
Case Presentation 2- 3D Cine Image-Guided
Peripheral Intervention |
Seung-Woon Rha |
| 1:25 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
|
|
|
|
